Procedural sedation in morbidly obese patients can present special challenges, because of the cardiorespiratory changes associated with morbid obesity. This mini review presents various pharmacologic options available for sedation in these patients.
Cardiorespiratory; Alfentanil; Dexmedetomidine; Remifentanil